These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 8750649)

  • 1. Clinical application of serum tumor abnormal protein in prostate cancer patients.
    Fu L; Zhang C; Wang Z; Tao W; Zhu J; Zhou Y; Sun C; Xue B; Yu M; Xu L; Zang Y
    BMC Cancer; 2024 May; 24(1):665. PubMed ID: 38822321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Urinary miRNAs in the Diagnosis, Management and Follow- Up of Prostatic Cancer.
    Ziogou A; Giannakodimos A; Giannakodimos I
    Microrna; 2023; 12(2):83-86. PubMed ID: 36999432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MRI in the PSA screening era.
    George AK; Pinto PA; Rais-Bahrami S
    Biomed Res Int; 2014; 2014():465816. PubMed ID: 25250323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of serum prostate cancer markers using a nanopore thin film based optofluidic chip.
    Alzghoul S; Hailat M; Zivanovic S; Que L; Shah GV
    Biosens Bioelectron; 2016 Mar; 77():491-8. PubMed ID: 26457734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are elevated mitochondrial DNA fragments in prostatic inflammation a potential biomarker for prostate cancer?
    Aferin U; Bahtiyar N; Onaran I; Ozkara H
    Arch Ital Urol Androl; 2023 Sep; 95(3):11610. PubMed ID: 37791550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atopy and prostate cancer: Is there a link between circulating levels of IgE and PSA in humans?
    Van Hemelrijck M; Karagiannis SN; Rohrmann S
    Cancer Immunol Immunother; 2017 Dec; 66(12):1557-1562. PubMed ID: 28795218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate Cancer Specificity of PCA3 Gene Testing: Examples from Clinical Practice.
    Marks LS; Bostwick DG
    Rev Urol; 2008; 10(3):175-81. PubMed ID: 18836536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extremely Elevated Prostate-Specific Antigen in Acute Prostatitis: A Case Report.
    Nepal A; Sharma P; Bhattarai S; Mahajan Z; Sharma A; Sapkota A; Sharma A
    Cureus; 2023 Aug; 15(8):e43730. PubMed ID: 37727194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated prostate-specific antigen (PSA) levels from acute COVID-19 infection confounding cancer disease surveillance.
    Tan YJ; Tan Y
    QJM; 2024 Jun; 117(5):378-379. PubMed ID: 38229252
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between Mental Disorders, Smoking or Alcoholism and Benign Prostate Disease.
    Chantada-Tirado P; Chantada-Abal V; Cózar-Ortiz JD; Chantada-Tirado C; Cózar-Olmo JM; Esteban-Fuertes M; Alvarez-Ossorio-Rodal A; Flores-Fraile J; Márquez-Sánchez MT; Padilla-Fernández BY; Lorenzo-Gómez MF
    Clin Pract; 2024 Feb; 14(1):250-264. PubMed ID: 38391406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficiency of the serum prostate specific antigen levels in diagnosing prostatic enlargements.
    Sp I; Ramona I; Sukesh
    J Clin Diagn Res; 2013 Jan; 7(1):82-4. PubMed ID: 23450716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retraction Note to: Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study.
    Shafiee R; Shariat A; Khalili S; Malayeri HZ; Mokarizadeh A; Anissian A; Ahmadi MR; Hosseini E; Naderafif M; Mohsenzadeh S; Rasoulian MH; Rezapour R; Pourzaer M
    Tumour Biol; 2016 Nov; ():. PubMed ID: 27826942
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucins as Potential Biomarkers for Early Detection of Cancer.
    Gautam SK; Khan P; Natarajan G; Atri P; Aithal A; Ganti AK; Batra SK; Nasser MW; Jain M
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidental detection of localized prostate cancer with low PSA by computed tomography scan: A report of two cases.
    Bilim V; Watanabe A; Horigome R; Ito S; Hoshi S
    Clin Case Rep; 2022 Dec; 10(12):e6736. PubMed ID: 36540877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reliable biomarker derived from plasmalogens to evaluate malignancy and metastatic capacity of human cancers.
    Smith RE; Lespi P; Di Luca M; Bustos C; Marra FA; de Alaniz MJ; Marra CA
    Lipids; 2008 Jan; 43(1):79-89. PubMed ID: 18046593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen (PSA) and cancer-associated serum antigen (CASA) in distinguishing benign and malignant prostate disease.
    Devine PL; Walsh MD; McGuckin MA; Quin RJ; Hohn BG; Clague A; Samaratunga H
    Int J Biol Markers; 1995; 10(4):221-5. PubMed ID: 8750649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue polypeptide-specific antigen: a discriminative parameter between prostate cancer and benign prostatic hypertrophy.
    Marrink J; Oosterom R; Bonfrer HM; Schröder FH; Mensink HJ
    Eur J Cancer; 1993; 29A(4):570-1. PubMed ID: 7679580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen (protein and mRNA) analysis in the differential diagnosis and staging of prostate cancer.
    Castaldo G; Cecere G; di Fusco V; Prezioso D; d'Armiento M; Salvatore F
    Clin Chim Acta; 1997 Sep; 265(1):65-76. PubMed ID: 9352130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.
    Zidan HE; Abdul-Maksoud RS; Elsayed WSH; Desoky EAM
    IUBMB Life; 2018 May; 70(5):437-444. PubMed ID: 29522280
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.